Background. Previous attempts to target arterial smooth muscle cells (SMCs) for gene delivery using liposomal or retroviral methods were limited by low transfection efficiency. We therefore evaluated the efficiency of adenovirus-mediated gene delivery in cultured vascular SMCs and in an in vivo model of balloon injury-induced SMC cell proliferation.
T he smooth muscle cell (SMC) proliferation associated with arterial injury remains a major obstacle to the long-term success of coronary angioplasty. Angioplasty failure rates of 25% to 50% within 6 months have been reported and confirmed by several authors.1-5 Previous attempts to modulate this cellular proliferation have included various mechanical and pharmacological therapies that have been the subject of several reviews.6-9 More recently, many efforts have been directed against various growth factors, their receptors, or cellular proto-oncogenes thought to play an important role in SMC proliferation.'0-19 Although several of these methods have shown encouraging results in vitro and, more recently, in vivo, all approaches have both practical and theoretical drawbacks. Hence, while one or more of these therapeutic strategies may ultimately show clinical efficacy, the need for more powerful and specific approaches is compelling.
Gene therapeutic techniques offer the promise of efficiently transferring genes, whose products may convey therapeutic benefit, to specific groups of cells. One potential application in the treatment of restenosis would be to transduce neointimal cells with genes whose products inhibit cell growth or increase their susceptibility to cytotoxic agents. Previous efforts to directly transduce arterial segments in vivo have used liposomal or retroviral methods to transfer marker genes into endothelial cells or SMCs. [20] [21] [22] [23] [24] The feasibility of such efforts, however, has been limited by a low transfection efficiency. In in vivo models, estimates of gene transfer into arterial segments range from fewer than 1 in 10 000 cells transduced with retroviral methods24 to fewer than 1 in 1000 cells using liposomes. 23 Replication-deficient recombinant adenoviral vectors have previously been shown to be efficient for transferring exogenous genes to a wide variety of cells in vivo. [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] Such vectors can be manipulated to encode for recombinant gene products up to 7.5 kilobases (kb) in length. 37 The recombinant virus can be propagated in certain mammalian cell lines that serve to complement the growth of replication-defective adenovirus. This allows for the potential production of viral stocks of 1x 101" plaque-forming units (pfu)/mL or greater. Additionally, transduction by adenovirus as opposed to retrovirus does not depend on active replication of the host cell and therefore could be used to target both quiescent and actively replicating cells.3738 With this knowledge, we have studied the feasibility of using adenovirusmediated gene transfer to target medial SMCs of normal arterial segments and both medial and neointimal SMCs after vascular injury.
Methods

Adenovirus Vectors
The replication-deficient recombinant adenovirus (Ad.RSV3gal) has previously been described. 28 M199 (Biofluids) was used to dilute stock viral solution to the appropriate concentration. The solution was then evacuated, the external carotid was ligated, and the incision was closed. All rats in this group were killed at 3 days after infection, and the carotid was subsequently harvested, fixed, and stained as described below.
To assess gene transfer to areas of vascular injury, the left carotid artery was exposed and injured as previously described.41'42 Briefly, the common carotid and its external branch were exposed and encircled using 4-0 silk ties. An arteriotomy was made in the external carotid artery. A 2F Fogarty embolectomy catheter was then passed into the common carotid, filled with 0.2 mL of air, and passed back and forth three times in order to denude the endothelial lining of the vessel. The carotid artery of one group of rats was exposed to virus immediately after injury. Adenoviral solution consisting of 0.5 to 1.Ox 109 pfu adenovirus in 100 ,L of M199 was gently delivered into the common carotid lumen via the external carotid artery. After the 45-minute incubation, the external carotid was ligated, the common carotid was reperfused, and the animal was allowed to recover as previously described.
In three other groups of animals, carotid arteries were exposed to virus 3, 7, or 12 days after injury. These animals were reanesthetized at the prescribed time interval after injury. The common carotid artery was exposed through the previous incision, and a portion of the artery measuring approximately 1.3 cm was isolated between 1-mm microvascular clamps. An arteriotomy was then made in the common carotid artery using a 24-gauge catheter, and the vessel was irrigated with 50 to 100 ,uL of normal saline. Adeno Ad.R8VNgI Ion (min)
The incision was closed, and the animal was allowed to recover as described above. Ad.RSVj~gal (n=5) or AdCFTR (n=2). Nine rats were infected 3 days after injury with Ad.RSVf3gal (n=7) or AdCFTR (n=2). For the 7-day time point, a total of 9 rats were used. Six of these rats infected with Ad.RSVI3gal (n=3) or AdCFTR (n=3) were killed at the usual 3 days after infection, whereas an additional 3 rats, all infected with Ad.RSVJ8gal, were killed 2 weeks after infection to assess persistence of gene expression. Finally, a total of 4 rats were infected 12 days after injury with Ad.RSVfBgal (n=2) or AdCFTR (n=2).
Results
In Vitro Gene Transfer
We first sought to assess the efficiency of adenovirusmediated gene transfer in cultured primary rat aorticSMCs. In SMCs exposed to adenovirus-containing media for 5 minutes and returned to low-serum media for 24 hours, P-gal expression was detected in approximately 25% of cells ( Figs 1A and iD) . With increasing time of incubation in adenovirus-containing media, a higher percentage of cells stained positive. With cells exposed to adenovirus-containing media for 1 hour and returned to low-serum media for 24 hours before staining, close to 70% of cells appeared positive (Figs 1B and iD). As expected, the predominant staining was intranuclear, since the (-gal gene was modified by the addition of a nuclear localizing sequence. A nucleardominant blue stain was not seen in mock-infected cells ( Fig 1C) (Fig iD) . As shown in Fig 2A, p- (Fig 3A) . This was again limited to less than 5% of the vessel surface. Histology revealed only occasional neointimal or medial SMC staining ( Fig  3B) . Control segments treated with AdCFTR either immediately (n=2) or 3 days after injury (n=2) showed no staining for p-gal activity.
In contrast, markedly increased P-gal activity was observed in segments in which infection was delayed until 7 days after injury (n=3). At this time, we found that neointima covered most but not all of the arterial surface. Intense staining, indicative of gene transfer and expression, was evident on gross examination in each of the arterial segments obtained from these animals exposed to p-gal-containing adenovirus (Fig 4C) . Histo- logical examination showed staining limited almost exclusively to the neointima (Fig 4D) . We Fig  4F) . Arterial segments infected 7 days after injury with control AdCFTR virus (n=3) showed no visible staining on gross or microscopic examination (Figs 4A and 4B ).
In the final group in this series of experiments, we exposed arteries to Ad.RSVPgal at 12 days after injury and harvested the vessels 3 days later (n=2). At this point, the neointima is thicker and covers most of the arterial surface. Each of these segments showed uniform staining of their luminal surface (Fig SA) . Histology again showed efficient gene transfer that was selective for neointimal cells (Fig 5B) . In general, the cells located in the more superficial portions of the neointima appeared to have a higher efficiency of gene transfer. Carotid segments in which animals were infected 12 days after injury with the control adenovirus AdCFTR showed no evidence of staining (n=2).
In the 3 animals in which distal organs were harvested in order to evaluate gene expression at distal sites, no P-gal staining could be visualized in any area by gross or histological evaluation.
Persistence of Gene Expression
In a separate group consisting of 3 animals, we made a preliminary assessment of the persistence of gene expression. Rats were infected 7 days after injury, and their carotid arteries were harvested 2 weeks later.
Analysis of ,l-gal expression in these segments showed persistence of ,-gal activity in each of the 3 animals. However, relative to segments harvested 3 days after infection, expression was markedly diminished as assessed by counting the number of cells with nucleardominant blue stain per high power field (data not shown). Ad.RSVPgal (which contains a nuclear localization signal) in that it is generally weaker and thereby requires prolonged exposure to X-Gal solutions. We noted that control arteries left in X-Gal solution overnight, rather than the usual 4 hours that we used in this study, developed a faint blue staining pattern. Of importance, however, is the fact that this weak staining was cytoplasmic rather than nuclear.
In injured arteries, expression of the p-gal gene product was confined almost exclusively to neointimal cells. The mechanism responsible for this difference in susceptibility between neointimal and medial SMCs to adenovirus-mediated gene transfer and expression is unclear. One probable explanation is that a physical barrier, most likely the internal elastic lamina, prevents diffusion of virus into medial layers. Thus, neointimal cells that reside on the luminal side of the internal elastic lamina are able to be infected, whereas medial SMCs, which reside deep to the internal elastic lamina, are not. Alternatively, the process of injury-induced neointimal proliferation may affect the expression of the as yet uncharacterized adenoviral cell surface receptor. Increased expression of the target viral receptor by proliferating neointimal cells could explain their efficient and selective uptake of adenovirus. A third possibility is that both medial and neointimal cells were equally infected but that only neointimal cells possess those endogenous transcription factors needed for efficient expression of RSV-driven transcripts. Of note, however, in our in vitro experiments we found no appreciable difference in adenoviral infection between quiescent and proliferating SMCs. These in vitro experiments argue against large differences in viral receptor number or in RSV-dependent transcription between quiescent and proliferating SMCs and therefore support the concept of a physical barrier to infectivity.
In this study, we routinely evaluated gene expression 3 days after infection. In three segments, however, we assessed p-gal staining 2 weeks after infection. These segments showed continued but diminished expression of the marker gene. Previous studies in endothelial cells in vitro have shown that gene expression peaks around 7 days after infection and persists for at least 14 Ad.RSVfigal, we could not detect 13-gal expression in the brain, liver, or heart of each of 3 animals in which these organs were harvested. This suggests that adenoviral gene transfer can in large part be limited to discrete vascular segments without subjecting distal organs to infection. Although the present study uses only the histochemical marker gene p-gal, it suggests that other recombinant adenoviral vectors, with genes whose products have cytotoxic or antiproliferative effects, could be targeted to neointimal cells. Such viral constructs would be expected to have similarly high efficiency and selectivity of expression in neointimal cells. If the expression of such recombinant molecules inhibits the proliferation of SMCs, adenovirus-mediated gene transfer may be a useful strategy in the treatment of restenosis.
